Role of the vagal afferents in substance P‐induced respiratory responses in anaesthetized rabbits
- 1 September 1987
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 131 (1) , 63-71
- https://doi.org/10.1111/j.1748-1716.1987.tb08206.x
Abstract
Since substance P (SP)‐like immunoreactivity has been demonstrated in vagal sensory fibres of bronchopulmonary origin, it was considered of interest to (1) characterize the pattern of responses to SP injected into the pulmonary as well as the systemic arterial system, and (2) assess the types of vagal afferents that are affected by SP. Experiments were performed on 15 pentobarbital‐anaesthetized, spontaneously breathing rabbits. Efferent phrenic nerve activity was monitored as an index of central respiratory neural output. Intra‐atrial injections of SP into the pulmonary circulation (100 ng kg‐1) increased the respiratory rate, and peak integrated phrenic amplitude by 47 ± 8 and 40 ± 4%, respectively, above the controls. In addition, SP elicited augmented breaths (ABs) within 2–3 s in 67% of the trials. In contrast to right atrial injections, no ABs and no significant changes in respiratory rate were observed in response to intra‐aortic injections of SP (100 ngkg–). Tidal phrenic activity rise after aortic injections of SP was significantly less as compared with right atrial administrations of SP. Since both routes of administration decreased the arterial blood pressure to the same extent, these respiratory responses were not likely secondary to cardiovascular changes. After administration of an SP antagonist (d‐Arg‐d‐Trp7.9, Leu11, SP), respiratory responses to SP were significantly attenuated. Also, the rate of occurrence of ABs elicited by releasing the tracheal occlusions was reduced (control 95vs. 14% SP antagonist). Bilateral vagotomy abolished the tachypnoeic response and reduced the magnitude of the phrenic nerve increments caused by right atrial injection of SP. Recordings from vagal sensory fibres showed that SP excites the irritant and C‐fibre receptors of bronchopulmonary origin. It is suggested that SP can excite respiration through its action on pulmonary receptors innervated by vagal nerves.Keywords
This publication has 17 references indexed in Scilit:
- Effect of Substance P antagonist on the hypoxia‐induced carotid chemoreceptor activityActa Physiologica Scandinavica, 1984
- Effects and distribution of vagal capsaicin‐sensitive substance P neurons with special reference to the trachea and lungsActa Physiologica Scandinavica, 1983
- Substance P-antagonists: a new type of pharmacological toolTrends in Pharmacological Sciences, 1982
- Neuropeptide Y (NPY)‐like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic functionActa Physiologica Scandinavica, 1982
- The contribution of sensory inputs to the pattern generation of breathingCanadian Journal of Physiology and Pharmacology, 1981
- Characteristics and rate of occurrence of spontaneous and provoked augmented breathsActa Physiologica Scandinavica, 1981
- Substance P in the vagal sensory ganglia: Localization in cell bodies and pericellular arborizationsJournal of Comparative Neurology, 1980
- Substance P as a Transmitter CandidateAnnual Review of Neuroscience, 1980
- Peptide neurons in the vagus, splanchnic and sciatic nerves*Acta Physiologica Scandinavica, 1978
- The role of the vagus nerves, peripheral chemoreceptors and other afferent pathways in the genesis of augmented breaths in cats and rabbitsRespiration Physiology, 1972